Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype-guided dual antiplatelet therapy in cerebrovascular disease: assessing the risk and benefits for ethnic populations.

Expert review of cardiovascular therapy - 1 Jan 2000

Qureshi Kasim, Farooq Muhammad U, Gorelick Philip B

Abstract excerpt

INTRODUCTION: Cerebrovascular disease is a leading cause of morbidity and mortality in the world and antiplatelet therapy is a main pharmacologic means of secondary prevention. Clinical information has accumulated about benefit of dual antiplatelet therapy in certain clinical scenarios, genetic causes of antiplatelet resistance and its effect on clinical outcomes, and ethnic and geographic distributions of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cerebrovascular Disorders
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Platelet Aggregation Inhibitors

Share to Stroke

Source

Identifiers

PMID: 37551687
DOI: 10.1080/14779072.2023.2245754

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype-guided dual antiplatelet therapy in cerebrovascular disease: assessing the risk and benefits for ethnic populations.PMID 37551687Read ↗

Pharmacogenomics in Stroke and Cardiovascular Disease: State of the ArtSemantic proximity Read ↗

Epoxidase inhibitor-aspirin resistance and the relationship with genetic polymorphisms: a reviewSemantic proximity Read ↗

CYP2C19 Genotype-Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure.Semantic proximity Read ↗

Genetic susceptibility to cerebrovascular disease: A systematic review.Semantic proximity Read ↗

Genetics of Ischemic Stroke, Stroke-Related Risk Factors, Stroke Precursors and TreatmentsSemantic proximity Read ↗

Genotype- and phenotype-directed antiplatelet therapy selection in patients with acute coronary syndromes.Semantic proximity Read ↗

Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the Week.Semantic proximity Read ↗

The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD).Semantic proximity Read ↗

Pharmacogenetics and stroke.Semantic proximity Read ↗

Give genotype-guided dual antiplatelet therapy a second CHANCE.Semantic proximity Read ↗

Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk - Never Judge a Book by Its Cover.Semantic proximity Read ↗

Use of genetic data to guide therapy in arterial disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.